Can Clavispora lusitaniae cause ringworm-like skin eruptions in immunocompetent individuals?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Clavispora lusitaniae and Ringworm-Like Eruptions in Immunocompetent Individuals

Clavispora lusitaniae can cause ringworm-like cutaneous eruptions in immunocompetent individuals, though this is exceptionally rare. The organism is primarily known as a cause of invasive fungal infections in immunocompromised hosts, but documented cutaneous presentations do exist in otherwise healthy patients.

Evidence for Cutaneous C. lusitaniae Infection

The strongest evidence comes from a documented case of cutaneous infection caused by C. lusitaniae in an immunocompetent pediatric patient 1. This case involved a one-and-a-half-year-old boy who presented with acute, severe inflammation around his left eyelid that failed to respond to antibacterial therapy. Scanning electron microscopy revealed hyphae and spores on the surface of crusty exudates that had penetrated into the tissue, with subsequent identification confirmed through 26S RNA gene and ITS region sequencing 1.

Critical Diagnostic Considerations

The key challenge is that C. lusitaniae cutaneous infections can clinically mimic dermatophyte infections (true ringworm), but they are fundamentally different organisms requiring different management:

  • True ringworm is caused by dermatophyte fungi (Trichophyton, Microsporum, Epidermophyton species) affecting keratinized tissues 2, 3
  • C. lusitaniae is a yeast (now classified as Clavispora lusitaniae) that can cause superficial infections mimicking dermatophytosis

The clinical presentation may be indistinguishable without laboratory confirmation, which is why definitive diagnosis requires:

  • Direct microscopy showing yeast forms (not dermatophyte hyphae)
  • Culture with characteristic yeast colony morphology
  • Molecular identification via gene sequencing when available 1

Clinical Pitfalls to Avoid

  1. Do not assume all ringworm-like lesions are dermatophyte infections - failure to obtain fungal culture in treatment-resistant cases delays appropriate therapy
  2. Do not dismiss fungal etiologies in immunocompetent patients - while C. lusitaniae typically causes invasive disease in immunocompromised hosts, cutaneous infection can occur in healthy individuals 1, 4
  3. Do not rely solely on clinical appearance - other conditions including eczema can mimic tinea, and atypical fungal pathogens like C. lusitaniae can mimic dermatophytes 3

Treatment Approach

When C. lusitaniae cutaneous infection is confirmed:

  • Topical azole antifungals are typically effective for localized cutaneous candidiasis (though specific data for C. lusitaniae cutaneous infection is limited)
  • Systemic antifungal therapy may be required for extensive or treatment-resistant cases
  • Echinocandins or fluconazole are standard for invasive Candida infections, though cutaneous infections generally respond to azoles 5
  • Monitor for treatment response and consider alternative diagnoses if no improvement occurs

Important Caveats

The literature on C. lusitaniae causing superficial cutaneous infections in immunocompetent hosts is extremely limited, with most reports describing invasive disease (peritonitis, endophthalmitis, fungemia) in immunocompromised patients or those with indwelling devices 6, 4. The single well-documented case of cutaneous infection 1 demonstrates this is possible but emphasizes its rarity.

In practical terms: If you encounter a ringworm-like eruption that fails standard antifungal therapy for dermatophytes, obtain fungal culture and consider atypical pathogens including Candida species. The diagnosis of C. lusitaniae cutaneous infection should prompt evaluation for underlying immunocompromise or predisposing factors, even if the patient appears immunocompetent.

Related Questions

What is the appropriate treatment for ringworm in a 2‑year‑old child?
What topical antifungal treatments are appropriate for a 3‑year‑old and an 18‑month‑old with suspected ring‑worm, and what key questions should I ask before starting therapy?
What is the best topical antifungal treatment for ringworm (tinea corporis) on the cheek?
In a patient with well‑controlled hemoglobin A1c who is taking empagliflozin (Jardiance) and now has a groin fungal infection (tinea cruris), should the empagliflozin be continued and what is the appropriate treatment for the rash?
What is the recommended management for a patient with acute pancreatitis complicated by pneumoperitoneum?
What molecule allosterically regulates glucokinase regulatory protein (GKRP)?
What is single-fiber electromyography (SFEMG)?
In a patient with normal colon and intestinal biopsies and diverticulosis, who has markedly elevated methylmalonic acid and homocysteine, anemia with high total iron and iron saturation but normal ferritin, what is the most likely diagnosis and appropriate management?
What is the recommended treatment and follow‑up for a 57‑year‑old African‑American male on lisinopril 10 mg daily and metformin 500 mg twice daily who presents for routine follow‑up with uncontrolled stage 2 hypertension (blood pressure 156/102 mm Hg), oxygen saturation 93 % on room air, and hemoglobin A1c 6.3 %?
In a patient with confirmed pernicious anemia and normal colon and small‑bowel biopsies who also has diverticulosis, what additional symptoms and signs should be assessed?
In a 56-year-old man with hypertension on lisinopril whose blood pressure remains >130/80 mmHg, after adding hydrochlorothiazide 12.5 mg his previously stable serum creatinine now shows impaired renal function; what is the appropriate next step in management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.